The historical rank and industry rank for Ibnsina Pharma's FCF Margin % or its related term are showing as below:
CAI:ISPH'
s FCF Margin % Range Over the Past 10 Years
Min: -2.28 Med: -0.9 Max: 4.55
Current: 1.11
During the past 10 years, the highest FCF Margin % of Ibnsina Pharma was 4.55%. The lowest was -2.28%. And the median was -0.90%.
CAI:ISPH's FCF Margin % is ranked better than 50% of 116
companies
in the Medical Distribution industry
Industry Median: 1.06
vs CAI:ISPH: 1.11
Ibnsina Pharma FCF Margin % Related Terms
Ibnsina Pharma FCF Margin % Historical Data
* Premium members only.
The historical data trend for Ibnsina Pharma's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CAI:ISPH vs MCK, CAH, COR: FCF Margin % Comparison
For the Medical Distribution subindustry, Ibnsina Pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ibnsina Pharma FCF Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Ibnsina Pharma's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Ibnsina Pharma's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ibnsina Pharma (CAI:ISPH) has a FCF Margin % of 0.80% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Ibnsina Pharma and its competitors. According to the industry distribution chart, Ibnsina Pharma ranks #58 out of 116 companies in the Medical Distribution industry, placing it in the top 50%.
Is Ibnsina Pharma's FCF Margin % too high?
Ibnsina Pharma's current FCF Margin % is 0.80%. The Medical Distribution industry median FCF Margin % is 1.06. Ibnsina Pharma's value of 0.80% is 24.5% below this industry median. Based on the distribution chart, Ibnsina Pharma ranks #58 out of 116 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Ibnsina Pharma has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ibnsina Pharma's FCF Margin % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Ibnsina Pharma ranks #58 out of 116 companies for FCF Margin %. This puts Ibnsina Pharma in the upper half of its industry. The industry median FCF Margin % is 1.06. Ibnsina Pharma's value of 0.80% is 24.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Distribution company?
The median FCF Margin % among Medical Distribution companies is 1.06, based on 116 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ibnsina Pharma's current FCF Margin % of 0.80% is 24.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Ibnsina Pharma and its competitors. For the Medical Distribution industry, the median FCF Margin % is 1.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ibnsina Pharma's current FCF Margin % is 0.80%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ibnsina Pharma stock overvalued right now?
Based on GuruFocus' analysis, Ibnsina Pharma (CAI:ISPH) is currently considered Fairly Valued. The stock's GF Value™ is E£10.51, compared to a current price of E£11.30 — trading 7.5% above its estimated fair value. The current FCF Margin % is 0.80% and 24.5% below the Medical Distribution industry median of 1.06. Ibnsina Pharma's overall GF Score™ is 87/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Ibnsina Pharma (CAI:ISPH), the current FCF Margin % is 0.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ibnsina Pharma (CAI:ISPH) Overvalued in 2026?
Based on GuruFocus' analysis, Ibnsina Pharma stock appears to be overvalued.
The current stock price of E£11.30 is trading 7.5% above its estimated GF Value™ of E£10.51.
GuruFocus considers Ibnsina Pharma to be Fairly Valued.
Key valuation signals for CAI:ISPH:
FCF Margin %: 0.80%
GF Value™: E£10.51 vs. price of E£11.30 (7.5% above fair value)
Industry Position: 24.5% below the Medical Distribution median (#58 of 116)
No single metric tells the full story. See the CAI:ISPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ibnsina Pharma is an Egypt-based pharmaceutical distribution company. It is engaged in purchasing and selling in wholesale and distribution of pharmaceutical, semi- pharmaceutical, and cosmetic products. It distributes a portfolio of pharmaceutical products from local and multinational pharmaceutical companies to retail pharmacies, wholesalers, hospitals, and public health institutions. In addition, the company also offers services including warehousing and logistics, marketing solutions, importation, packaging, market research, and analysis.
87GF Score
Get the complete analysis for CAI:ISPH
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAI:ISPH has been successfully added to your 
